MedPath

clinical evaluation of Panchtikta Churna in Madhumeha (type 2 Diabetes Mellitus)

Phase 2
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complicationsHealth Condition 2: E119- Type 2 diabetes mellitus without complicationsHealth Condition 3: E119- Type 2 diabetes mellitus without complicationsHealth Condition 4: E119- Type 2 diabetes mellitus without complicationsHealth Condition 5: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/01/061587
Lead Sponsor
Ayurvedic and Unani Tibbia college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients of age group 18 to 60 years of either sex.

2. Fasting plasma glucose = 126 mg/dl or Post Prandial glucose level = 200 mg/dl.

3. The HbA1c levels should lie within the range of > 6.5% to <8.5%

( According to American Diabetes Association, ADA ,2022 guidelines)

Exclusion Criteria

1. Patients having sign and symptoms of complication of Type 2 Diabetes Mellitus like Nephropathy,

Retinopathy, Neuropathy.

2. Patients with gestational diabetes mellitus or pregnant women .

3. Patients suffering from any chronic diseases such as Bronchial asthma , COPD, Chronic kidney disease ,

Ischaemic heart diseases , Fatty liver stage 3 and Chronic illness of other body organs , uncontrolled High

blood pressure (Systolic more than 160 and diastolic more than 100 mm of Hg)

4. Patients who are diagnosed with malignancy of any system.

5. Patients currently using oral hypoglycemic agents (Conventional).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease in HbA1c values in patientsTimepoint: 3 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
20% decrease in Fasting blood sugar or PP blood sugar or HbA1c.Timepoint: 3 months
© Copyright 2025. All Rights Reserved by MedPath